A share price of Longevity Health Holdings Inc [XAGE] is currently trading at $0.18, up 12.50%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The XAGE shares have gain 9.69% over the last week, with a monthly amount glided 39.18%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Longevity Health Holdings Inc experienced fluctuations in its stock price throughout the past year between $0.10 and $2.93. Longevity Health Holdings Inc [NASDAQ: XAGE] shares were valued at $0.18 at the most recent close of the market.
Analyzing the XAGE fundamentals
Trailing Twelve Months sales for Longevity Health Holdings Inc [NASDAQ:XAGE] were 0.05M which represents -99.53% decline. Gross Profit Margin for this corporation currently stands at -0.27% with Operating Profit Margin at -99.34%, Pretax Profit Margin comes in at -213.6%, and Net Profit Margin reading is -236.55%. To continue investigating profitability, this company’s Return on Assets is posted at -8.08, Equity is 4.13 and Total Capital is 1.14. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -0.14.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.1574 points at the first support level, and at 0.1394 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.1892, and for the 2nd resistance point, it is at 0.2030.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Longevity Health Holdings Inc [NASDAQ:XAGE] is 0.15. As well, the Quick Ratio is 0.13, while the Cash Ratio is 0.03. Considering the valuation of this stock, the price to sales ratio is 105.75.
Transactions by insiders
Recent insider trading involved Upton Richard A, Director, that happened on Sep 13 ’24 when 5000.0 shares were purchased. Director, Gregory Kathryn completed a deal on Sep 06 ’24 to buy 1260.0 shares. Meanwhile, Director Sturgeon Patrick A bought 1261.0 shares on Sep 06 ’24.
